Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 16;220(11):1816–1825. doi: 10.1093/infdis/jiz395

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — Geometric mean respiratory syncytial virus–A neutralizing antibody titers (A), geometric mean respiratory syncytial virus–B neutralizing antibody titers (B), and geometric mean palivizumab-competing antibody concentrations (C) until day 90 (per-protocol set). Error bars represent 95% confidence intervals. The raw data for the 60 μg and 120 μg groups are so similar as to be indistinguishable in Figure 3C. Abbreviations: 30 RSV-PreF/60 RSV-PreF/120 RSV-PreF, group of women who received 1 dose of the unadjuvanted RSV vaccine containing 30, 60, or 120 μg of RSV prefusion F protein; CI, confidence interval; Control, group of women who received 1 dose of placebo; GMC, geometric mean concentration; GMT, geometric mean titer; RSV, respiratory syncytial virus.